Speeding Up Clinical Trials by Making Drug Production Local
Waltham, MA – June 14, 2021 – Professor Tim Jamison’s company Snapdragon Chemistry helps turn the latest innovations in chemistry into impactful drugs. In this MIT News article, Snapdragon Chemistry and Tim Jamison, cofounder, MIT Professor, and Associate Provost, are highlighted for their work in helping pharmaceutical companies manufacture drugs locally to shorten the time it takes for new drugs to get to patients.
About Snapdragon Chemistry
Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff. For more information, please contact email@example.com.